A COMPARATIVE-STUDY OF PALA, PALA PLUS 5-FU, AND 5-FU IN ADVANCED BREAST-CANCER

被引:0
|
作者
MANN, GB
HORTOBAGYI, GN
BUZDAR, AU
YAP, HY
VALDIVIESO, M
机构
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DIV MED,MED BREAST SERV,6723 BERTNER AVE,HOUSTON,TX 77030
[2] MT ELIZABETH MED CTR,CTR CANC SCREENING & TREATMENT,SINGAPORE,SINGAPORE
[3] AMER INT HOSP,ZION,IL
关键词
D O I
10.1002/1097-0142(19850915)56:6<1320::AID-CNCR2820560617>3.0.CO;2-R
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1320 / 1324
页数:5
相关论文
共 50 条
  • [31] 5-FU CARDIOTOXICITY
    SANANI, S
    SPAULDING, MB
    MASUD, ARZ
    CANTY, R
    CANCER TREATMENT REPORTS, 1981, 65 (11-1): : 1123 - 1125
  • [32] Effects of 5-FU
    Wigmore, Peter M.
    Mustafa, Sarah
    El-Beltagy, Maha
    Lyons, Laura
    Umka, Jariya
    Bennett, Geoff
    CHEMO FOG: CANCER CHEMOTHERAPY-RELATED COGNITIVE IMPARIMENT, 2010, 678 : 157 - 164
  • [33] Prodrugs of 5-FU
    Kaye, SB
    ANNALS OF ONCOLOGY, 1998, 9 : 23 - 23
  • [34] Oral 5-FU analogues in the treatment of breast cancer
    Bunnell, CA
    Winer, EP
    ONCOLOGY-NEW YORK, 1998, 12 (10): : 39 - 43
  • [35] The cost of 5-FU
    Ryan, RF
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2001, 107 (06) : 1613 - 1613
  • [36] 5-FU: finally!
    Robert, Jacques
    BULLETIN DU CANCER, 2019, 106 (03) : 173 - 174
  • [37] Colorectal cancer - Is there an alternative to 5-FU?
    Bleiberg, H
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (04) : 536 - 541
  • [39] SEQUENTIAL METHOTREXATE AND 5-FU IN BREAST-CANCER RESISTANT TO THE CONVENTIONAL APPLICATION OF THESE DRUGS
    HERRMANN, R
    MANEGOLD, C
    SCHROEDER, M
    TIGGES, FJ
    BARTSCH, H
    JUNGI, F
    FRITZE, D
    CANCER TREATMENT REPORTS, 1984, 68 (10): : 1279 - 1281
  • [40] PHARMACOKINETICS OF N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) AND 5-FLUOROURACIL (5-FU) COMBINATION IN BEAGLE DOGS
    MILLER, AA
    MOORE, EC
    LOO, TL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 245 - 245